|
The Impact of Maternal CMV Infection on Birth Outcomes |
1 R03 AI151426-01A1 |
STOWE, RAYMOND PRESTON |
NIAID |
2021 |
|
Project 2: Costimulation Pathways in CNS Disease |
5 P01 AI039671-24 |
HAFLER, DAVID A |
NIAID |
2021 |
|
Project 3: Integrative approach tounderstanding the mechanism ofcostimulation
[Parent Title: Costimulatory Mechanisms of Autoimmunity] |
5 P01 AI039671-24 |
SHARPE, ARLENE H |
NIAID |
2021 |
|
Innate Immune Response to S. aureus Biofilm |
5 P01 AI083211-13 |
KIELIAN, TAMMY L |
NIAID |
2021 |
|
The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome |
5 R01 AI143710-03 |
WU, PINGSHENG |
NIAID |
2021 |
|
Determining Enhanced Inflammatory B cell Function in African Americans with MS |
5 R21 AI144819-02 |
VARTANIAN, TIMOTHY |
NIAID |
2021 |
|
IMMUNE RESPONSES IN THE MOTHER-INFANT DYAD INDUCED BY FETAL SURGERY, AND ASSOCIATIONS WITH PREMATURITY |
5 R21 AI151208-02 |
ENNINGA, ELIZABETH ANN LIESER |
NIAID |
2021 |
|
Long non-coding RNA signatures to track treatment responses in multiple sclerosis |
5 R44 AI145505-03 |
SPURLOCK, CHARLES FLOYD |
NIAID |
2021 |
|
Treating Brain Swelling in Pediatric Cerebral Malaria |
5 U01 AI126610-05 |
TAYLOR, TERRIE ELLEN |
NIAID |
2021 |
|
Project 3: Effects of Age on Cellular, Transcriptomic and Biochemical Influenza Signatures |
5 U19 AI089992-10 |
SHAW, ALBERT C |
NIAID |
2021 |